Ekocorp

Ekocorp EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is -11.45. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -9.07 — a change of 26.15% (lower).

EV/FCF

-11.45

YoY

26.15%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Ekocorp is 2020 -11.45 . EV/FCF (Enterprise Value to Free Cash Flow) of Ekocorp was 2019 -9.07 . It decreases by 26.15% lower compared to the previous year.

The Ekocorp EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2015
-4.52 NGN
Jan 1, 2016
60.30 NGN
Jan 1, 2017
-53.89 NGN
Jan 1, 2018
-247.62 NGN
Jan 1, 2019
-9.07 NGN
Jan 1, 2020
-11.45 NGN
The Ekocorp EV/FCF history
YEAREV/FCFYoY
-11.45+26.15%
-9.07-96.34%
-247.62+359.44%
-53.89-189.38%
60.30-1,432.86%
-4.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

EV/FCF (Enterprise Value to Free Cash Flow) of Ekocorp is -11.45 in 2020.

EV/FCF (Enterprise Value to Free Cash Flow) of Ekocorp changed from -9.07 to -11.45, representing a 26.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Ekocorp since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Ekocorp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ekocorp

All Key Metrics — Ekocorp